Medical device for delivering a therapeutic agent and method of preparation
Abstract
A device useful for localized delivery of a therapeutic agent is provided. The device includes a structure including a porous polymeric material and an elutable therapeutic agent in the form of a solid, gel, or neat liquid, which is dispersed in at least a portion of the porous polymeric material. Methods for making a medical device having a blood-contacting surface is also provided. One method involves: providing a structure comprising a porous material; contacting the structure comprising a porous material with a concentrating agent to disperse the concentrating agent throughout at least a portion of the porous material; contacting the structure comprising a porous material and the concentrating agent with a solution of a therapeutic agent; and removing the therapeutic agent from solution within the porous material at the locations of the concentrating agent. Another method involves multiple immersion steps without the use of a concentrating agent.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A medical device having at least one blood-contacting surface comprising:
a porous polymeric material comprising a nonswellable biostable polymer; and an elutable therapeutic agent in the form of a solid, gel, or neat liquid, which is dispersed in at least a portion of the porous polymeric material.
2 . The medical device of claim 1 wherein the porous polymeric material comprises a film.
3 . The medical device of claim 1 wherein the nonswellable biostable polymer is selected from the group consisting of silicone, polyurethane, polysulfone, cellulose, polyethylene, polypropylene, polyamide, polyester, polytetrafluoroethylene, and a combination of two or more of these materials.
4 . The medical device of claim 3 wherein the porous polymeric material comprises an integral portion of the device.
5 . The medical device of claim 1 wherein the therapeutic agent comprises an antithrombotic material.
6 . The medical device of claim 5 wherein the antithrombotic material is heparin.
7 . The medical device of claim 1 wherein the therapeutic agent is a peptic drug.
8 . The medical device of claim 1 wherein the device has a generally cylindrical shape.
9 . The device of claim 8 wherein the device is selected from the group consisting of a catheter, a stent, and a guide wire.
10 . The device of claim 1 wherein the device has a generally sheet-like shape.
11 . The medical device of claim 1 wherein the device is an intralumenal stent.
12 . An intralumenal stent comprising:
a generally cylindrical stent body; and and an adherent layer on the stent body comprising a porous polymeric material and an elutable therapeutic agent in the form of a solid, gel, or neat liquid, which is dispersed in at least a portion of the porous polymeric material.
13 . A method for making a medical device comprising:
(a) providing a structure comprising a porous material; (b) contacting the structure comprising a porous material with a concentrating agent to disperse the concentrating agent throughout at least a portion of the porous material; (c) contacting the structure comprising a porous material and the concentrating agent with a solution of a therapeutic agent; and (d) removing the therapeutic agent from solution within the porous material at the locations of the concentrating agent.
14 . The method of claim 13 wherein precipitating agent is selected from the group of a binding agent, sequestering agent, a nucleating agent, a seed crystal, or combinations thereof.
15 . The method of claim 13 wherein the porous material is selected from the group consisting of a natural hydrogel, a synthetic hydrogel, silicone, polyurethane, polysulfone, cellulose, polyethylene, polypropylene, polyamide, polyester, polytetrafluoroethylene, and a combination of two or more of these materials.
16 . The method of claim 13 wherein the therapeutic agent is an antithrombotic material.
17 . The method of claim 13 wherein the step of removing the therapeutic agent from solution comprises reducing the temperature of the solution of the therapeutic agent.
18 . The method of claim 13 wherein the step of removing the therapeutic agent from solution comprises changing the pH of the solution of the therapeutic agent.
19 . The method of claim 13 wherein the step of removing the therapeutic agent from solution comprises changing the ionic strength of the solution of the therapeutic agent.
20 . A method for making a medical device comprising:
(a) providing a structure comprising a porous material; (b) immersing the structure comprising a porous material in a saturated solution of a therapeutic agent for a sufficient period of time to allow the solution to fill the porous material; (c) removing the medical device from the solution; (d) drying the medical device; and (e) repeating steps (b) through (d) to provide a therapeutic agent dispersed within the porous material.
21 . The method of claim 20 further comprising a step of removing air bubbles from the porous material while being immersed in the solution of the therapeutic agent.
22 . The method of claim 21 wherein the step of removing air bubbles from the porous material comprises applying ultrasonics, reduced pressure, elevated pressure, or a combination thereof, to the solution.
23 . The method of claim 20 wherein the medical device is a stent.
24 . The method of claim 23 wherein the stent has a porous polymeric film thereon.
25 . The method of claim 23 further comprising a step of applying an overlayer of a polymer.Join the waitlist — get patent alerts
Track US2002055710A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.